This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

A Lack of News and Buzz at 'JPM16' Sinks Biotech Stocks

Biotech stocks large and small were plummeting as 2016's painful start began to turn torturous.

Brainstorm Recycles ALS Stem Cell Data to Boost Sagging Stock

A much-hyped press conference reveals nothing new about Brainstorm's stem-cell therapy for ALS.

Vertex Takes a Pass on 2016 Orkambi Cystic Fibrosis Sales Guidance

Vertex presents to investors on Monday at the J.P. Morgan Healthcare Conference.

2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks

I'm only making one big prediction this year: The five-year party which saw biotech stocks outperform the broader markets comes to an end in 2016.

MannKind Perilously Close to Bankruptcy After Sanofi Exit

MannKind is as close to financial insolvency as it can possibly be without actually declaring bankruptcy after Sanofi terminated its agreement and will no longer sell the inhaled insulin Afrezza.

Editas' IPO Challenge: Edit Investor Expectations as Well as Diseased Genes

Editas Medicine is most definitely the hottest biotech initial public offering of a very young 2016.

Feuerstein's Heroes and Zeroes of Biotech Investing in 2015

My biotech and pharma superlatives for 2015.

The Winners for Best and Worst Biopharma CEOs of 2015 are...

Congrats to Allergan's Brent Saunders for winning the 2015 Best Biopharma CEO award.

Shkreli 'Was Running Turing Like a Hedge Fund'

Martin Shkreli resigned as chief executive officer of Turing Pharmaceuticals Friday following his arrest on charges of securities fraud.

The Naughty List: Finalists for Worst Biopharma CEO of 2015

These five candidates for Worst Biopharma CEO of 2015 have bathed in the muck of mediocrity long enough to warrant your scorn.

Page 3 of 351
Top Rated Stocks Top Rated Funds Top Rated ETFs